Exposing a virus’s hiding place reveals new potential vaccine
By figuring out how a common virus hides from the immune system, scientists have identified a potential vaccine to prevent sometimes deadly respiratory infections in humans.
Read moreRSV
Vanderbilt Doctors Discuss When to Visit Emergency Departments for Cold and Flu Symptoms
While it can be difficult to decipher symptoms, Michele Walsh, MD, assistant professor of Pediatrics and medical director of the Pediatric Emergency Department at Children’s Hospital, offers tips on when it is best to bring a child to an emergency department (ED) versus making a call or visit to the family pediatrician.
Read moreVaccine against RSV could be in sight, researchers say
A vaccine for the common and sometimes deadly RSV (respiratory syncytial virus) has been elusive, but scientists say a new discovery puts them much closer to success.
Read more
Mesa Biotech to Launch Molecular, Sample-to-Answer RSV Test at the 2019 AACC Annual Scientific Meeting
Mesa Biotech Inc., a privately-held, molecular diagnostic company that has developed an affordable, sample-to-answer, CLIA-waived PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis, today announced the launch of its respiratory syncytial virus test (RSV). Mesa will demonstrate its expanded, novel Accula™ Test System at the 71st American Association of Clinical Chemistry (AACC) Annual Meeting and Clinical Lab Expo. The Accula System’s RSV and Flu A/Flu B molecular tests will be on exhibit in Booth 3902. Sekisui Diagnostics distributes both products in the US under the Silaris™ brand.
Read more